CdcA4 Inhibitors
CdcA4 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the CdcA4 protein, also known as cell division cycle-associated protein 4. CdcA4 is an essential component of the cell cycle machinery, playing a crucial role in regulating the progression of cells through the various stages of division, particularly in the G1/S and G2/M phases. It is involved in modulating the activity of cyclin-dependent kinases (CDKs) and other cell cycle regulatory proteins, ensuring the proper timing of DNA replication, mitosis, and cellular growth. Inhibitors of CdcA4 are designed to disrupt these regulatory functions, effectively modulating the checkpoints that control cell division and proliferation.
Chemically, CdcA4 inhibitors are designed to interfere with the protein's ability to interact with CDKs or its other molecular partners within the cell cycle regulatory network. These inhibitors may bind directly to CdcA4's active or binding domains, preventing it from forming complexes necessary for its role in regulating CDK activity or other critical cell cycle regulators. The development of CdcA4 inhibitors involves structure-based drug design, high-throughput screening, and structure-activity relationship (SAR) studies to identify compounds with high specificity and selectivity. By blocking CdcA4 function, these inhibitors allow researchers to investigate the precise molecular mechanisms controlling cell cycle progression and understand how disruptions in CdcA4-mediated regulation impact cellular division and growth. These insights are crucial for studying how cells maintain balance in proliferation and division under various physiological conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, a labdane diterpene from the Indian Coleus plant, is known to activate adenylate cyclase, leading to increased cAMP levels. Elevated cAMP can influence cell cycle regulation, potentially affecting proteins like CDCA4. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, a metabolite of Vitamin A, is involved in gene expression regulation during cell growth and differentiation. It may indirectly affect CDCA4 activity by altering the expression of genes involved in the cell cycle. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. By altering chromatin structure and gene expression, it can indirectly impact the activity of cell cycle-related proteins, possibly including CDCA4. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. By modulating this pathway, PD98059 can indirectly influence cell cycle regulation and potentially CDCA4 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. Inhibiting PI3K can lead to alterations in cell survival and growth pathways, indirectly affecting cell cycle proteins such as CDCA4. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a central regulator of cell growth and metabolism. This inhibition can indirectly affect cell cycle regulation, potentially impacting CDCA4 activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, affecting DNA methylation and gene expression. This can indirectly impact the expression and function of cell cycle-related proteins, including CDCA4. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor, leading to increased cytosolic calcium levels. This can influence various cellular processes, including cell cycle regulation, potentially affecting CDCA4. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, a known phosphodiesterase inhibitor, can increase cAMP levels in cells. This can indirectly influence cell cycle-related signaling pathways, potentially affecting CDCA4 activity. | ||||||